TACSTD2 and neoplasm: Moreover, these researchers transferred TROP2-positive tumor exosomes to TROP2-negative tumor cells to elevate the percentage of tumor cells targetable by TROP2-redirected CAR-Ts and to tackle the limitation of antigen heterogeneity in solid tumors (234).